TREATMENT READING
Transitional Cell Cancer of the Renal Pelvis and Ureter
Choose a source section by treatment, subtype or setting. Patient and professional reading are labelled separately.
Selected text from the National Cancer Institute, with original links and dates. This Triangle reading page is not an NCI PDQ summary. Source topics may be broader than an individual diagnosis.
Certain factors affect prognosis (chance of recovery) and treatment options.
Treatment Option Overview for Transitional Cell Cancer of the Renal Pelvis and Ureter
Key Points
There are different types of treatment for patients with transitional cell cancer of the renal pelvis and ureter.
The following type of treatment is used:
Surgery
New types of treatment are being tested in clinical trials.
Fulguration
Segmental resection of the renal pelvis
Laser surgery
Regional chemotherapy and regional immunotherapy
Treatment for transitional cell cancer of the renal pelvis and ureter may cause side effects.
Follow-up care may be needed.
Treatment of Localized Transitional Cell Cancer of the Renal Pelvis and Ureter
Treatment of Regional Transitional Cell Cancer of the Renal Pelvis and Ureter
Treatment of Metastatic or Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle